Staidson Beijing Biopharma (300204) — Financial Flexibility Index

Latest as of September 2025: -0.06x

Staidson Beijing Biopharma (300204) has a Financial Flexibility Index of -0.06x as of September 2025. Free cash flow of CN¥-23.52 Million (operating CF CN¥-39.18 Million minus capex CN¥15.66 Million) represents 0% of total liabilities (CN¥404.22 Million). Check cash flow reinvestment rate of Staidson Beijing Biopharma to assess the company's total reinvestment commitment from operating cash flow.

Financial Flexibility Index

-0.06x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥-23.52 Million
Operating CF − Capex

Total Liabilities

CN¥404.22 Million
CNY

Capital Expenditures

CN¥15.66 Million
CNY

Staidson Beijing Biopharma Financial Flexibility Index (2007–2025)

Historical Financial Flexibility Index trend for Staidson Beijing Biopharma across 19 annual periods. For the full cash flow conversion analysis, see Staidson Beijing Biopharma (300204) cash flow conversion.

Annual Financial Flexibility Index for Staidson Beijing Biopharma (2007–2025)

Year-by-year free cash flow to debt coverage for Staidson Beijing Biopharma. Explore Staidson Beijing Biopharma cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2025 -0.11x CN¥-49.05 Million CN¥-125.68 Million CN¥459.48 Million ▲ +38.1%
2024 -0.17x CN¥-40.16 Million CN¥-63.68 Million CN¥232.85 Million ▲ +72.5%
2023 -0.63x CN¥-195.32 Million CN¥-227.47 Million CN¥311.55 Million ▼ -66.1%
2022 -0.38x CN¥-119.09 Million CN¥-175.60 Million CN¥315.45 Million ▲ +1.5%
2021 -0.38x CN¥-105.83 Million CN¥-162.07 Million CN¥276.25 Million ▼ -56.6%
2020 -0.24x CN¥-65.73 Million CN¥-114.60 Million CN¥268.70 Million ▼ -153.3%
2019 0.46x CN¥104.25 Million CN¥44.34 Million CN¥227.18 Million ▼ -44.6%
2018 0.83x CN¥260.54 Million CN¥165.08 Million CN¥314.30 Million ▲ +8.5%
2017 0.76x CN¥320.19 Million CN¥273.64 Million CN¥419.14 Million ▲ +38.2%
2016 0.55x CN¥239.00 Million CN¥212.55 Million CN¥432.32 Million ▼ -16.1%
2015 0.66x CN¥254.96 Million CN¥231.01 Million CN¥387.06 Million ▼ -11.4%
2014 0.74x CN¥221.32 Million CN¥206.85 Million CN¥297.54 Million ▲ +41.4%
2013 0.53x CN¥134.39 Million CN¥111.36 Million CN¥255.47 Million ▼ -32.2%
2012 0.78x CN¥149.07 Million CN¥90.19 Million CN¥192.15 Million ▼ -78.6%
2011 3.62x CN¥171.36 Million CN¥87.01 Million CN¥47.32 Million ▲ +144.4%
2010 1.48x CN¥146.15 Million CN¥63.91 Million CN¥98.66 Million ▼ -22.6%
2009 1.91x CN¥55.56 Million CN¥42.37 Million CN¥29.03 Million ▲ +69.4%
2008 1.13x CN¥33.03 Million CN¥16.23 Million CN¥29.25 Million ▲ +849.6%
2007 0.12x CN¥5.75 Million CN¥5.41 Million CN¥48.35 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities